CardioComm Solutions Establishes Research Partnership with University of Texas at Austin for HeartCheck™ ECG Services in Clinical Neuroendocrinology
HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has entered into a partnership agreement with the Clinical Neuroendocrinology Laboratory … Read more